Cancer incidence among persons with fragile X syndrome in Finland: a population-based study

被引:23
作者
Sund, R. [1 ]
Pukkala, E. [2 ,3 ]
Patja, K. [4 ]
机构
[1] Natl Res & Dev Ctr Welf & Hlth STAKES, FI-00531 Helsinki, Finland
[2] Finnish Canc Registry, FIN-00170 Helsinki, Finland
[3] Univ Tampere, FIN-33101 Tampere, Finland
[4] Natl Publ Hlth Inst, Helsinki, Finland
关键词
cancer; fragile X syndrome; incidence; intellectual disability; MARTIN-BELL SYNDROME; CGG REPEAT; EXPRESSION; PROTEIN; MALES; TUMOR; TRANSCRIPTION; CONSEQUENCES; INDIVIDUALS; PREMUTATION;
D O I
10.1111/j.1365-2788.2008.01116.x
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Fragile X syndrome is a common inheritable cause of intellectual disability (ID) and is characterised by a large number of CGG repeats at the gene FMR1 located on the X-chromosome. It has been reported that this genetic mechanism may protect against malignant transformations. We extracted from the Finnish registry on persons with ID a cohort of 302 persons with a fragile X diagnosis during 1982-1986. Follow-up for cancer incidence was performed in the Finnish Cancer Registry until the end of the year 2005. There were 11 reported cancers during the mean follow-up of 21.4 years per person. The expected number of cancers based on the average Finnish population was 13.8 and no statistically significant protective effect was detected [standardised incidence ratios (SIR) 0.80, confidence interval (CI) 95% 0.40-1.4]. An increased risk for lip cancer was found (SIR 23, CI 95% 2.8-85). Confirmation of hypotheses about the mechanisms linking FXS and cancer needs further research.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 40 条
[1]   Cyclic adenosine monopho sphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells [J].
Al-Wadei, Hussein A. N. ;
Schuller, Hildegard M. .
CANCER DETECTION AND PREVENTION, 2006, 30 (05) :403-411
[2]  
Au W Y, 2003, Haematologica, V88, pECR13
[3]   Whole genome microarray analysis of gene expression in subjects with fragile X syndrome [J].
Bittel, Douglas C. ;
Kibiryeva, Nataliya ;
Butler, Merlin G. .
GENETICS IN MEDICINE, 2007, 9 (07) :464-472
[4]  
CUNNINGHAM M, 1988, CANCER-AM CANCER SOC, V62, P2383, DOI 10.1002/1097-0142(19881201)62:11<2383::AID-CNCR2820621122>3.0.CO
[5]  
2-R
[6]  
DEGRAAFF E, 1995, AM J HUM GENET, V57, P609
[7]   DEMONSTRATION OF THE FRA(X) IN LYMPHOCYTES, FIBROBLASTS, AND BONE-MARROW IN A PATIENT WITH A TESTICULAR-TUMOR [J].
DELPOZO, BC ;
MILLARD, PR .
JOURNAL OF MEDICAL GENETICS, 1983, 20 (03) :225-227
[8]  
DROUIN V, 1992, ARCH FR PEDIATR, V49, P477
[9]   Nasopharyngeal carcinoma in a boy with fragile X syndrome [J].
Ferrari, A ;
Meazza, C ;
Casanova, M .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (07) :597-600
[10]   Chromosome fragility: molecular mechanisms and cellular consequences [J].
Freudenreich, Catherine H. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :4911-4924